Have a feature idea you'd love to see implemented?
Let us know!
RMTI Rockwell Medical Inc
Price (delayed)
$3.61
Market cap
$112.02M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.17
Enterprise value
$114.53M
Rockwell Medical is a biopharmaceutical company dedicated to transforming anemia management in a wide variety of therapeutic areas and across the globe, improving the lives of very sick patients. The
Highlights
RMTI's equity has surged by 147% year-on-year and by 14% since the previous quarter
The gross profit has soared by 88% YoY and by 38% QoQ
Key stats
What are the main financial stats of RMTI
Market
Valuations
Earnings
Shares outstanding
31.03M
Market cap
$112.02M
Enterprise value
$114.53M
Price to earnings (P/E)
N/A
Price to book (P/B)
4.66
Price to sales (P/S)
1.16
EV/EBIT
N/A
EV/EBITDA
73.8
EV/Sales
1.21
Revenue
$94.37M
EBIT
-$2.59M
EBITDA
$1.55M
Free cash flow
-$5.22M
Per share
Balance sheet
Liquidity
EPS
-$0.17
Free cash flow per share
-$0.17
Book value per share
$0.78
Revenue per share
$3.1
TBVPS
$1.37
Total assets
$53.03M
Total liabilities
$29.53M
Debt
$14.38M
Equity
$23.5M
Working capital
$14.86M
Debt to equity
0.61
Current ratio
2
Quick ratio
1.52
Net debt/EBITDA
1.62
Margins
Efficiency
Dividend
EBITDA margin
1.6%
Gross margin
13.4%
Net margin
-5.1%
Operating margin
-3.3%
Return on assets
-9.2%
Return on equity
-22%
Return on invested capital
-8.9%
Return on capital employed
-6.8%
Return on sales
-2.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
RMTI stock price
How has the Rockwell Medical stock price performed over time
Intraday
3.44%
1 week
0.84%
1 month
-4.75%
1 year
107.47%
YTD
91.01%
QTD
-9.07%
Financial performance
How have Rockwell Medical's revenue and profit performed over time
Revenue
$94.37M
Gross profit
$12.69M
Operating income
-$3.09M
Net income
-$4.77M
Gross margin
13.4%
Net margin
-5.1%
The gross profit has soared by 88% YoY and by 38% QoQ
The company's operating margin has surged by 75% YoY and by 57% QoQ
Rockwell Medical's operating income has surged by 69% YoY and by 53% QoQ
The company's net margin has surged by 67% YoY and by 47% QoQ
Growth
What is Rockwell Medical's growth rate over time
Valuation
What is Rockwell Medical stock price valuation
P/E
N/A
P/B
4.66
P/S
1.16
EV/EBIT
N/A
EV/EBITDA
73.8
EV/Sales
1.21
The EPS has soared by 70% YoY and by 53% from the previous quarter
RMTI's equity has surged by 147% year-on-year and by 14% since the previous quarter
RMTI's price to book (P/B) is 86% higher than its last 4 quarters average of 2.5 and 8% higher than its 5-year quarterly average of 4.3
RMTI's price to sales (P/S) is 93% higher than its last 4 quarters average of 0.6 and 16% higher than its 5-year quarterly average of 1.0
Rockwell Medical's revenue has increased by 25% YoY and by 9% from the previous quarter
Efficiency
How efficient is Rockwell Medical business performance
The ROS has soared by 79% YoY and by 61% from the previous quarter
RMTI's return on equity has surged by 75% year-on-year and by 52% since the previous quarter
The return on invested capital has surged by 70% year-on-year and by 58% since the previous quarter
Rockwell Medical's return on assets has surged by 64% YoY and by 47% QoQ
Dividends
What is RMTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for RMTI.
Financial health
How did Rockwell Medical financials performed over time
Rockwell Medical's total assets is 80% more than its total liabilities
Rockwell Medical's total assets has increased by 39% YoY and by 4.5% from the previous quarter
RMTI's quick ratio is up by 31% YoY and by 15% QoQ
The company's debt is 39% lower than its equity
RMTI's equity has surged by 147% year-on-year and by 14% since the previous quarter
The debt to equity has plunged by 64% YoY and by 12% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.